Found: 201
Select item for more details and to access through your institution.
Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022.
- Published in:
- Die Pathologie, 2024, v. 45, n. 6, p. 381, doi. 10.1007/s00292-024-01329-2
- By:
- Publication type:
- Article
Multi-label semantic segmentation of magnetic resonance images of the prostate gland.
- Published in:
- Discover Artificial Intelligence, 2024, v. 4, n. 1, p. 1, doi. 10.1007/s44163-024-00162-z
- By:
- Publication type:
- Article
Are there limits of robotic partial nephrectomy? TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumors.
- Published in:
- Journal of Surgical Oncology, 2018, v. 118, n. 1, p. 206, doi. 10.1002/jso.25103
- By:
- Publication type:
- Article
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1061, doi. 10.1007/s00262-022-03328-9
- By:
- Publication type:
- Article
Risikoadaptierte Prostatakarzinomfrüherkennung 2.0 – Positionspapier der Deutschen Gesellschaft für Urologie 2024.
- Published in:
- Die Urologie, 2024, v. 63, n. 9, p. 893, doi. 10.1007/s00120-024-02437-w
- By:
- Publication type:
- Article
Das metastasierte kastrationsresistente Prostatakarzinom: praxisrelevante Hilfestellungen für individuelle Therapieentscheidungen.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Das Primärstaging mittels PSMA-PET verbessert die Vorhersage von Prostatakarzinomrezidiven.
- Published in:
- Die Urologie, 2023, v. 62, n. 12, p. 1326, doi. 10.1007/s00120-023-02208-z
- By:
- Publication type:
- Article
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 4933, doi. 10.3390/cancers15204933
- By:
- Publication type:
- Article
Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 461, doi. 10.3390/cancers15020461
- By:
- Publication type:
- Article
High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2548, doi. 10.3390/cancers13112548
- By:
- Publication type:
- Article
Investigation of the halo-artifact in <sup>68</sup>Ga-PSMA-11-PET/MRI.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183329
- By:
- Publication type:
- Article
Ion Prostate Irradiation (IPI) -- a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-202
- By:
- Publication type:
- Article
Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-202
- By:
- Publication type:
- Article
Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 4, p. 1332, doi. 10.1111/jcmm.17141
- By:
- Publication type:
- Article
Ureterocystoneostomy in complex oncological cases with an 'Uebelhoer' modified Boari bladder flap.
- Published in:
- Langenbeck's Archives of Surgery, 2017, v. 402, n. 8, p. 1271, doi. 10.1007/s00423-017-1554-0
- By:
- Publication type:
- Article
Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma.
- Published in:
- Langenbeck's Archives of Surgery, 2017, v. 402, n. 4, p. 637, doi. 10.1007/s00423-016-1543-8
- By:
- Publication type:
- Article
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
- Published in:
- Disease Markers, 2018, p. 1, doi. 10.1155/2018/7308168
- By:
- Publication type:
- Article
Outcome of radical prostatectomy for incidental carcinoma of the prostate.
- Published in:
- BJU International, 2009, v. 103, n. 11, p. 1478, doi. 10.1111/j.1464-410X.2008.08279.x
- By:
- Publication type:
- Article
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
- Published in:
- BJU International, 2009, v. 103, n. 7, p. 978, doi. 10.1111/j.1464-410X.2008.08132.x
- By:
- Publication type:
- Article
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
- Published in:
- BJU International, 2008, v. 102, n. 5, p. 610, doi. 10.1111/j.1464-410X.2008.07669.x
- By:
- Publication type:
- Article
Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
- Published in:
- BJU International, 2008, v. 102, n. 3, p. 389, doi. 10.1111/j.1464-410X.2008.07618.x
- By:
- Publication type:
- Article
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
- Published in:
- BJU International, 2008, v. 101, n. 11, p. 1347, doi. 10.1111/j.1464-410X.2008.07571.x
- By:
- Publication type:
- Article
Single-institution experience with primary tumours of the male urethra.
- Published in:
- BJU International, 2008, v. 101, n. 8, p. 964, doi. 10.1111/j.1464-410X.2007.07347.x
- By:
- Publication type:
- Article
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
- Published in:
- BJU International, 2007, v. 100, n. 6, p. 1377, doi. 10.1111/j.1464-410X.2007.07165.x
- By:
- Publication type:
- Article
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269827
- By:
- Publication type:
- Article
Beta radioguided surgery: towards routine implementation?
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 3, p. 229, doi. 10.23736/S1824-4785.21.03358-6
- By:
- Publication type:
- Article
Implementation of radioguided surgery in prostate cancer.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 3, p. 202, doi. 10.23736/S1824-4785.21.03348-3
- By:
- Publication type:
- Article
Near‐infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device: A single center experience.
- Published in:
- Journal of Surgical Oncology, 2024, v. 129, n. 7, p. 1325, doi. 10.1002/jso.27618
- By:
- Publication type:
- Article
Recurrent prostate cancer: combined role for MRI and PSMA-PET in <sup>68</sup>Ga-PSMA-11 PET/MRI.
- Published in:
- European Radiology, 2024, v. 34, n. 7, p. 4789, doi. 10.1007/s00330-023-10442-4
- By:
- Publication type:
- Article
Systematische oder gezielte Fusionsbiopsie der Prostata.
- Published in:
- Die Urologie, 2023, v. 62, n. 5, p. 464, doi. 10.1007/s00120-023-02062-z
- By:
- Publication type:
- Article
Photodynamische transurethrale Resektion der Blase (TURB): mehr Schein als Sein: Ein Kommentar zur randomisierten Studie.
- Published in:
- Die Urologie, 2023, v. 62, n. 2, p. 181, doi. 10.1007/s00120-022-02000-5
- By:
- Publication type:
- Article
High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102560
- By:
- Publication type:
- Article
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 698, doi. 10.3390/biomedicines10030698
- By:
- Publication type:
- Article
Discordant prostate specific antigen test results despite WHO assay standardization.
- Published in:
- International Journal of Biological Markers, 2018, v. 33, n. 3, p. 275, doi. 10.1177/1724600818754750
- By:
- Publication type:
- Article
Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer.
- Published in:
- Genes, 2022, v. 13, n. 3, p. 422, doi. 10.3390/genes13030422
- By:
- Publication type:
- Article
To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic.
- Published in:
- PLoS ONE, 2020, v. 15, n. 9, p. 1, doi. 10.1371/journal.pone.0239027
- By:
- Publication type:
- Article
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 518, doi. 10.1007/s12325-021-01885-6
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 49, n. 1, p. 385, doi. 10.1007/s00259-021-05423-y
- By:
- Publication type:
- Article
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1200, doi. 10.1007/s00259-020-05040-1
- By:
- Publication type:
- Article
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 2, p. 469, doi. 10.1007/s00259-020-04934-4
- By:
- Publication type:
- Article
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2045, doi. 10.1007/s00259-018-4079-z
- By:
- Publication type:
- Article
Therapy assessment in prostate cancer using choline and PSMA PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, p. 78, doi. 10.1007/s00259-017-3723-3
- By:
- Publication type:
- Article
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 5, p. 776, doi. 10.1007/s00259-016-3594-z
- By:
- Publication type:
- Article
Comparison of hybrid Ga-PSMA PET/MRI and Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 1, p. 70, doi. 10.1007/s00259-015-3206-3
- By:
- Publication type:
- Article
The diagnostic value of PET/CT imaging with the Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 2, p. 197, doi. 10.1007/s00259-014-2949-6
- By:
- Publication type:
- Article
Radiation dosimetry and first therapy results with a I/I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 7, p. 1280, doi. 10.1007/s00259-014-2713-y
- By:
- Publication type:
- Article